ELREXFIO: payments to doctors
Payments that named ELREXFIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.7M
- Providers
- 7,650
- Transactions
- 26,470
- Average per transaction
- $255
The per-transaction average — $255 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,650 providers the average total is $882, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $6,739,439 | 99.9% |
| PBG Puerto RICO LLC | $4,118 | 0.1% |
| Array Biopharma Inc | $2,843 | 0.0% |